Advertisement
Research Article

Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza

  • Nathalie Landry mail,

    landryn@medicago.com

    Affiliation: Medicago Inc., Québec, Canada

    X
  • Brian J. Ward,

    Affiliation: Research Institute of the McGill University Health Center, Montreal General Hospital, Montreal, Canada

    X
  • Sonia Trépanier,

    Affiliation: Medicago Inc., Québec, Canada

    X
  • Emanuele Montomoli,

    Affiliation: Molecular Epidemiology Research Division, Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Siena, Italy

    X
  • Michèle Dargis,

    Affiliation: Medicago Inc., Québec, Canada

    X
  • Giulia Lapini,

    Affiliation: Molecular Epidemiology Research Division, Department of Physiopathology, Experimental Medicine and Public Health, University of Siena, Siena, Italy

    X
  • Louis-P. Vézina

    Affiliation: Medicago Inc., Québec, Canada

    X
  • Published: December 22, 2010
  • DOI: 10.1371/journal.pone.0015559

Reader Comments (0)

Post a new comment on this article